Caricamento...
Fc-binding antibody-recruiting molecules exploit endogenous antibodies for anti-tumor immune responses
Redirecting endogenous antibodies in the bloodstream to tumor cells using synthetic molecules is a promising approach to trigger anti-tumor immune responses. However, current molecular designs only enable the use of a small fraction of endogenous antibodies, limiting the therapeutic potential. Here,...
Salvato in:
| Pubblicato in: | Chem Sci |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
The Royal Society of Chemistry
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8157400/ https://ncbi.nlm.nih.gov/pubmed/34122826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/d0sc00017e |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|